[1]袁 冰,袁 洁,黄凯琳,等.基于“心脾相关,调气为先”探讨双心病中医治疗[J].陕西中医,2024,(11):1529-1532.[doi:DOI:10.3969/j.issn.1000-7369.2024.11.019]
　YUAN Bing,YUAN Jie,HUANG Kailin,et al.Based on “heart-spleen correlation,regulating Qi first” to explore Chinese medicine treatment of double heart disease[J].,2024,(11):1529-1532.[doi:DOI:10.3969/j.issn.1000-7369.2024.11.019]
点击复制

基于“心脾相关,调气为先”探讨双心病中医治疗
分享到：

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2024年11期
页码:
1529-1532
栏目:
学术探讨
出版日期:
2024-11-05

文章信息/Info

Title:
Based on “heart-spleen correlation,regulating Qi first” to explore Chinese medicine treatment of double heart disease
作者:
袁 冰1; 袁 洁1; 黄凯琳1; 廖家桢2 ; 吴焕林1
(1.北京中医药大学东直门医院心血管内科,北京 100700; 2.德国魁茨汀中医院,德国 汉堡 999035)
Author(s):
YUAN Bing; YUAN Jie; HUANG Kailin; LIAO Jiazhen; WU Huanlin
(Department of Cardiovascular Medicine,Dongzhimen Hospital,Beijing University of Chinese Medicine,Beijing 100700,China)
关键词:
郁病;  双心病;  胸痹;  心脾相关;  疏肝理气;  温胆汤;  小柴胡汤
Keywords:
Depression;  Double heart disease;  Xiongbi;  Heart-spleen interconnection;  Soothing liver and regulating Qi;  Wendan prescription;  Xiaochaihu prescription
分类号:
R 541.9
DOI:
DOI:10.3969/j.issn.1000-7369.2024.11.019
文献标志码:
A
摘要:
双心病是机体心脏与精神心理共同致病。随着社会生活压力不断增加,心血管疾病合并焦虑/抑郁的患病率也逐年上涨。双心病主要临床表现为胸痛、胸闷、心慌、抑郁善忧、心惊胆怯、精神紧张等。根据双心病临床症状特征,可归属于中医学“胸痹”“郁证”范畴。胸痹与郁证合而为病与目前西医提出的双心病相似,为“心主血脉”与“心主神明”共病体现的一类疾病,故“心身同治”“心神同调”成为目前治疗本病的关键。根据“五脏相关理论”,心脾两脏存在母子相生、经络相贯、阴阳相承、气血相济、神志相合的生理学关系。而情志失畅为双心病重要危险因素,与肝脏密切相关。同时肝木与脾土间存在五行相克的关系。温胆汤作为化痰经典方,具有健脾化痰、理气解郁之功效; 小柴胡汤具有疏解少阳枢机的功效,二者联用加强畅达气机之效。试从“心脾相关,调气为先”理论出发,探讨温胆汤联合小柴胡治疗双心病。
Abstract:
“Double heart disease” is condition caused by combined pathology of physical heart and psychological mind.With the continuous increase in social life stress.Prevalence of cardiovascular diseases accompanied by anxiety/depression has also risen year by year.“Double heart disease” primarily presents with clinical symptoms such as chest pain,chest tightness,palpitations,depression with tendency to worry,timidity,and mental tension.Based on clinical symptoms of “Double heart disease”,it can be categorized under traditional Chinese medicine concepts of “Xiongbi” and “Yu syndrome”.The combination of “Xiongbi” and “Yu syndrome” as disease is similar to “Double heart disease” proposed by modern western medicine,representing type of disease where the “heart governing blood vessels” and the “heart governing spirit” were both affected.Therefore,the key to treating this disease lies in “treating the body and mind together” and “regulating the heart and spirit together”. According to the “theory of five viscera interconnection,” the heart and spleen have physiological relationship of mother-child generation,meridian penetration,Yinyang inheritance,Qi-blood mutual aid,and spirit-integration.Emotional distress is significant risk factor for “Double heart disease” and is closely related to the liver.There was relationship of mutual restraint between the liver(wood)and the spleen(earth)in the five elements theory.Wendan prescription,classic phlegm-resolving formula,has effect of strengthening the spleen and resolving phlegm,as well as regulating Qi and relieving depression.Xiaochaihu prescription has effect of dispersing pivot of the Shaoyang.The combined use of these two enhances effect of unblocking the flow of Qi.Exploring the treatment of “Double heart disease” with Wendan prescription combined with Xiaochaihu prescription from the perspective of “heart-spleen interconnection,prioritizing the regulation of Qi.”

参考文献/References:

[1] 胡盛寿,王增武.《中国心血管健康与疾病报告2022》概述[J].中国心血管病研究,2023,21(7):577-600.
[2] DEHERT M,DETRAUX J,VANCAMPFORT D.The intriguing relationship between coronary heart disease and mental disorders[J].Dialogues Clin Neurosci,2018,20(1):31-40.
[3] GIULIANI M,SANTAGOSTINOBALDI G,CAPRA N,et al.The heart-mind relationship in women cardiovascular primary prevention:The role of depression anxiety distress and Type-D personality in the 10-years cardiovascular risk evaluation[J].Front Cardiovasc Med,2024,11:1308337.
[4] HOHLS J K,BEER K,AROLT V,et al.Association between heart-focused anxiety depressive symptoms health behaviors and healthcare utilization in patients with coronary heart disease[J].J Psychosom Res,2020,131:109958.
[5] 涂清鲜,姜黔峰,刘丹,等.冠心病患者PCI术治疗前后抑郁焦虑的特点及心理干预[J].中国老年学杂志,2019,39(5):1230-1232.
[6] 赵维哲,王超,赵海滨,等.基于“以证统病”思路探讨双心病的辨治策略[J].中医杂志,2023,64(7):682-685.
[7] 张洁洁,孟伟.名中医郭维琴基于“脏-神-气”论治心系疾病郁证经验[J].陕西中医,2023,44(7):933-935,940.
[8] 吴永青,宁博,李舒钰,等.基于络病理论从五脏之气络辨治双心病[J].中西医结合心脑血管病杂志,2024,22(5):953-956,960.
[9] 邓铁涛.略论五脏相关取代五行学说[J].广州中医学院学报,1988,4(2):65-68.
[10] 邓铁涛,郑洪.中医五脏相关学说研究——从五行到五脏相关[J].中国工程科学,2008,10(2):7-13.
[11] 吴焕林,赵益业,邹旭,等.冠心病的五脏相关论治[J].湖北中医杂志,2005,27(8):18-20.
[12] 刘佳,张立晶,金晓,等.基于“心脾相关”理论辨治冠心病合并抑郁探讨[J].环球中医药,2023,16(1):80-82.
[13] 李峰,毛萌,马捷.心脾相关理论及其应用——脾胃学说传承与应用专题系列(6)[J].中医杂志,2012,53(15):1265-1268.
[14] 赵益业,林晓忠,张敏州,等.邓铁涛教授以心脾相关学说诊治冠心病经验介绍[J].新中医,2007,39(4):5-6.
[15] 王翠,吴鹏亮,王苗,等.百郁解郁方治疗郁病临床研究[J].陕西中医,2019,40(8):1088-1090.
[16] 程铭威,靳利利,史振羽,等.疏肝理脾方治疗冠心病经皮冠状动脉介入术术后焦虑抑郁状态疗效研究[J].陕西中医,2022,43(9):1208-1211,1259.
[17] 王骕,董耀荣,冯其茂.心系病伴焦虑抑郁症中医治疗进展[J].陕西中医,2017,38(7):983-984.
[18] 万文蓉.张仲景小柴胡汤临床运用发微[J].中华中医药杂志,2013,28(1):124-127.
[19] 张晴,李彩英,林铭钐,等.基于圆运动理论探究小柴胡汤辨治双心病[J].辽宁中医杂志,2023,50(9):42-44.
[20] 刘璐,赵俊男,王碧晴,等.徐凤芹教授运用“和法”治疗“双心病”的临床经验[J].中西医结合心脑血管病杂志,2022,20(11):2101-2105.
[21] 文燕,陈珑,王挺,等.小柴胡汤加减治疗抑郁症临床疗效的Meta分析[J].上海中医药杂志,2022,56(1):34-38.
[22] 吴晨洁,王梦玺,曹培华,等.柴胡类方治疗双心病研究现状[J].山东中医杂志,2021,40(4):420-424.
[23] 张阔,王芷倩,杨静玉,等.小柴胡汤对围绝经期小鼠抑郁焦虑症状的改善作用及其机制[J].中国药理学与毒理学杂志,2019,33(10):876.
[24] 张慧,原晨,卢华锋,等.小柴胡汤对抑郁症大鼠JAK2/STAT3通路及小胶质细胞活化的影响[J].中国药师,2021,24(4):617-624.
[25] 刘鑫,于嘉祥,曲超,等.基于双心医学理论和分子对接技术探讨柴胡-黄芩药对治疗冠心病的作用机制[J].辽宁中医药大学学报,2023,25(2):184-191,221.
[26] 丁娜娜,陈毅恒,李伟峰,等.小柴胡汤及其类方辨治抑郁症的研究进展[J].中华中医药学刊,2023,41(6):69-73.
[27] 侯一鸣,郭峥,卞国本,等.温胆汤研究进展[J].中国中医基础医学杂志,2024,30(1):176-181.
[28] 徐留刚,王雅君.加味温胆汤联合黛力新治疗冠心病PCI术后焦虑抑郁患者的临床疗效及对Lp-PLA2的影响研究[J].广州中医药大学学报,2023,40(6):1342-1348.
[29] 祁祥,卢健棋,温志浩,等.基于网络药理学与分子对接的温胆汤治疗冠心病合并抑郁作用机制探讨[J].药物评价研究,2022,45(8):1540-1548.
[30] 张齐,何晓微,戴建业,等.抑郁、焦虑模型大鼠前额皮质神经元突触超微结构变化及加味温胆汤的情志双向调节作用分析[J].中华中医药学刊,2023,41(8):114-117,275.

相似文献/References:

[1]王 翠,吴鹏亮△,王 苗,等.百郁解郁方治疗郁病临床研究*[J].陕西中医,2019,(8):1088.

备注/Memo

备注/Memo:
基金项目:国家中医药管理局中医药国际合作专项课题(0610-2240NF021548)
更新日期/Last Update: 2024-11-11